Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis

Published:2022-12 Issue:6 Volume:48 Page:891-902
ISSN:1677-6119
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Hu Xianwen¹,Wu Yan¹,Yang Peiqing¹,Wang Ju¹,Wang Pan¹,Cai Jiong¹^ORCID

Affiliation:

1. Affiliated Hospital of Zunyi Medical University, China

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S1677-55382022000600891&tlng=en

Reference29 articles.

1. EAU-ESTRO-SIOG Guidelines on Prostate Cancer;Cornford P;Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. Eur Urol,2017

2. Overdiagnosis and overtreatment of prostate cancer;Loeb S;Eur Urol,2014

3. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature;Fütterer JJ;Eur Urol,2015

4. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging;Eder M;Bioconjug Chem,2012

5. Is There Use for FDG-PET in Prostate Cancer?;Jadvar H;Semin Nucl Med,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Learning-powered CT-less Multi-tracer Organ Segmentation from PET Images: A solution for unreliable CT segmentation in PET/CT Imaging;2024-08-28

2. Relationship Between Initial Volumetric 68Ga-PSMA PET/CT Parameters, and Clinical and Histopathological Data in Patients with Newly Diagnosed Prostate Cancer;2023-10-23

3. Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review;Frontiers in Oncology;2023-09-01

4. Is it necessary for all patients with suspicious lesions undergo systematic biopsy in the era of MRI-TRUS fusion targeted biopsy?;International braz j urol;2023-06

5. Efficacy and safety of salvage radiotherapy combined with endocrine therapy in patients with biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis of randomized controlled trials;Frontiers in Oncology;2023-01-24